Go to Pathways list
Support our work
DONATE NOW

Do we still need to excise primary focus of breast cancer in patients cCR following neoadjuvant therapy?

E-session 541 / CME accredited
Add to My Agenda

Expert:

Marie Jeanne T.F.D. Vrancken Peeters, expert of session 'Do we still need to excise primary focus of breast cancer in patients cCR following neoadjuvant therapy?'

Marie Jeanne T.F.D. Vrancken Peeters
The Netherlands Cancer Institute
Amsterdam, The Netherlands

Discussant:

Wojciech Wysocki, expert of session 'Do we still need to excise primary focus of breast cancer in patients cCR following neoadjuvant therapy?'

Wojciech Wysocki, Surgeon
Andrzej Frycz Modrzewski Krakow University
Krakow, Poland

Share on:

17
Sep 2020
18:15-19:00 CET

Top